mice
balbc
balbc
mice
purchas
charl
river
tokyo
japan
hous
specif
anim
facil
kept
accord
guidelin
set
committe
univers
nation
institut
advanc
industri
scienc
technolog
aist
infect
mice
transfer
laboratori
mous
inject
cultur
medium
right
frontal
lobe
deep
anesthesia
left
untreat
mice
inject
hind
footpad
lipopolysaccharid
lp
escherichia
coli
strain
sigma
tokyo
japan
pb
immunostain
carri
use
antibodi
reagent
list
tabl
section
label
mount
gold
antifad
reagent
invitrogen
carlsbad
ca
usa
examin
use
fluoresc
microscop
keyenc
osaka
japan
confoc
laser
scan
microscop
leica
microsystem
heidelberg
germani
tissu
patholog
examin
prepar
previous
intens
inflamm
hyperplast
atroph
state
spleen
score
accord
criteria
outlin
http
size
lymph
node
determin
measur
largest
area
hematoxylin
eosin
lymph
node
use
bz
analyz
keyenc
four
day
inject
thioglycol
periton
caviti
exud
cell
collect
wash
periton
caviti
seed
cell
per
well
plastic
chamber
slide
nalg
nunc
intern
rochest
ny
usa
cultur
overnight
condit
splenic
cell
describ
adher
cell
inocul
pfu
unit
viru
per
well
incub
specifi
time
period
viral
cell
visual
immunofluoresc
describ
protein
pon
spleen
purifi
accord
manufactur
instruct
affimetrix
santa
clara
ca
usa
minor
modif
use
assay
buffer
wako
osaka
japan
addit
cell
lysi
buffer
affimetrix
experiment
detail
describ
http
overal
surviv
fig
analyz
compar
method
differ
surviv
test
signific
test
otherwis
student
test
use
less
consid
indic
signific
although
mutant
mice
show
slightli
shorter
surviv
period
infect
fundament
differ
virul
among
differ
strain
mice
infect
observ
fig
show
infect
mice
die
within
day
dpi
viral
titer
prepar
organ
infect
mice
desir
shown
fig
viral
growth
mutant
mice
one
order
lower
compar
mice
fig
promin
inflamm
extend
brain
parenchyma
observ
infect
mutant
mice
fig
contrast
cell
infiltr
restrict
perivascular
area
less
extens
degre
infect
mice
fig
except
mening
region
alreadi
observ
hpi
mutant
mice
fig
b
report
cell
infiltr
beyond
space
arrowhead
fig
observ
frequent
brain
parenchyma
mutant
mice
mice
fig
alreadi
hpi
distribut
viral
antigen
brain
mutant
mice
appear
similar
manner
mice
previous
earli
phase
infect
hpi
viral
antigen
detect
mening
fig
b
appear
similar
frequenc
mutant
mice
fig
restrict
area
periventricular
area
fig
e
later
phase
infect
distribut
wide
area
brain
mutant
mice
manner
found
mice
fig
f
splenic
lesion
observ
infect
mice
character
deplet
leukocyt
fig
number
reduc
less
uninfect
mice
mani
apoptot
figur
white
arrow
fig
alreadi
appear
hpi
data
shown
accompani
hemosiderin
deposit
black
arrow
fig
appar
infect
mutant
mice
fig
spleen
infect
mutant
mice
hpi
show
rather
hyperplast
state
fig
cluster
leukocyt
arrow
fig
mainli
compos
cell
fig
e
interfollicular
area
appear
viral
antigen
earli
phase
infect
hpi
spleen
observ
similar
frequenc
fig
similar
infect
two
strain
also
detect
vitro
assay
fig
use
periton
exud
cell
challeng
thioglycol
compos
mainli
cell
data
shown
almost
differ
mutant
mice
shift
cytokin
level
infect
examin
pon
spleen
except
pon
spleen
fig
jhm
virus
known
prolifer
suppress
product
level
pon
increas
infect
mutant
mice
examin
express
immunofluoresc
found
wide
distribut
brain
parenchyma
viral
antigen
detect
hpi
although
mani
infect
cell
infiltr
mening
shown
upper
left
corner
fig
result
indic
infect
consid
produc
indirect
bystand
effect
cell
brain
parenchyma
inocul
lp
vivo
also
show
differ
inflammatori
respons
mutant
mice
mark
reduct
size
poplit
lymph
node
pln
inocul
lp
infect
mice
compar
lp
observ
fig
reduct
occur
mutant
mice
howev
mutant
mice
shown
refractori
lp
challeng
fig
possibl
refractori
mutant
mice
result
poor
recognit
lp
unlik
leukocyt
deriv
mutant
mice
produc
higher
level
cytokin
stimul
lp
vitro
mice
http
elucid
mechan
need
studi
includ
migrat
rate
leukocyt
pln
might
low
mutant
mice
challeng
infect
cell
pln
much
fewer
fig
count
less
compar
mice
fig
mani
viral
cell
mainli
detect
interfollicular
area
pln
obtain
infect
mice
inocul
lp
fig
wherea
viral
cell
detect
within
ln
parenchyma
infect
mice
untreat
lp
mutant
mice
fig
h
extend
inflamm
brain
rather
hyperplast
state
spleen
infect
mutant
mice
accompani
lower
viral
titrat
compar
mice
indic
mutant
mice
advantag
equip
viral
replic
inhibit
viral
clearanc
inflammatori
respons
earli
phase
infect
mice
indic
lex
structur
play
inhibitori
role
inflamm
acut
phase
infect
find
viral
titer
mutant
mice
brain
liver
infect
lower
mice
might
due
lower
infect
cell
lack
lex
structur
major
viral
receptor
carri
lex
howev
vivo
vitro
examin
reveal
differ
infect
mutant
mice
therefor
virolog
patholog
differ
observ
two
strain
would
like
result
differ
immun
respons
initi
phase
infect
initi
immun
respons
infect
trigger
pathogen
recognit
pattern
recognit
receptor
prr
includ
receptor
tlr
variou
class
receptor
lectin
lead
product
proinflammatori
cytokin
comparison
cytokin
product
two
strain
reveal
amount
pon
spleen
shift
infect
similarli
two
strain
less
almost
everi
case
therefor
similar
surviv
rate
spite
differ
viral
growth
brain
infect
two
strain
might
caus
cytokin
product
bystand
effect
rather
directli
due
injuri
infect
cell
bystand
effect
repres
elev
cytokin
level
caus
poor
prognosi
brain
injuri
observ
viral
infect
influenza
viral
encephalopathi
exhibit
almost
inflamm
viral
growth
type
brain
injuri
spleen
cytokin
level
examin
mice
reduc
infect
markedli
mutant
mice
howev
differ
level
mutant
mice
less
almost
everi
case
could
also
bystand
effect
uninfect
area
spleen
lead
elev
amount
whole
spleen
hpi
mutant
mice
although
report
mhv
infect
vitro
inhibit
may
mark
reduct
cytokin
product
spleen
mice
compar
mutant
mice
local
environ
especi
interfollicular
area
includ
margin
zone
viral
antigen
detect
earli
phase
influx
efflux
leukocyt
control
fibroblast
reticular
differ
immedi
inflammatori
respons
two
strain
observ
mice
challeng
lp
ligand
induc
lymphaden
region
lymph
node
mice
inflammatori
respons
poplit
lymph
node
toler
infect
occur
mutant
mice
far
size
lymph
node
concern
also
known
induc
accompani
immunolog
treatment
infect
caus
inhibitori
cascad
activ
recognit
ligand
play
import
role
immunolog
homeostasi
suppress
excess
immun
respons
activ
posit
cascad
trigger
activ
lex
structur
might
involv
neg
cascad
prr
pathway
caus
sever
inflamm
mutant
mice
viral
infect
mice
possibl
lack
lex
caus
increas
inflammatori
respons
posit
cascad
unlik
mutant
mice
refractori
vivo
challeng
lp
furthermor
level
cytokin
examin
vitro
stimul
lp
use
leukocyt
deriv
naiv
mutant
mice
lower
similar
compar
mice
howev
product
ifn
greater
cultur
leukocyt
deriv
mutant
compar
mice
exclud
possibl
mutant
mice
poorli
recogn
lp
collect
challeng
viral
infect
andor
lp
induc
differ
inflammatori
immun
respons
mutant
mice
earli
phase
challeng
differ
believ
result
differ
affin
like
caus
differ
cascad
respons
excess
immun
respons
trigger
activ
experiment
model
would
provid
opportun
studi
vivo
regulatori
mechan
involv
fucosyl
glycan
caus
inhibit
enhanc
inflamm
